Morgan Stanley Initiates Coverage On Tandem Diabetes Care With Equal-Weight Rating, Announces Price Target of $45
Morgan Stanley Initiates Coverage On Tandem Diabetes Care With Equal-Weight Rating, Announces Price Target of $45
摩根士丹利發起對tandem diabetes care的覆蓋,給予等權評級,宣佈目標價45美元。
Morgan Stanley analyst Patrick Wood initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight rating and announces Price Target of $45.
摩根士丹利分析師Patrick Wood開始覆蓋tandem diabetes care(納斯達克:TNDM),並給予等權重評級,宣佈45美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。